Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-040660

CFO sold 20,000 shares at an average $38.92 ($778,399)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Horn Howard CFO 2020-07-01 Sale −9,100 $37.72 $343,275 218,677 D: show line 1 in the form
Horn Howard CFO 2020-07-01 Sale −500 $38.78 $19,392 218,177 D: show line 2 in the form
Horn Howard CFO 2020-07-01 Sale −400 $39.33 $15,732 217,777 D: show line 3 in the form
Horn Howard CFO 2020-07-02 Sale −10,000 $40.00 $400,000 207,777 D: show line 4 in the form
Open-market sales · 20,000 sh · avg $38.92 · $778,399
Loading xslF345X03/doc4.xml…